Charcot-Marie-Tooth Disease Type 2 Caused by Mutation in the AARS1 Gene

Other names
Types
Causes
Symptoms
Diagnostic tests
Non-pharmacological treatments (therapies and others)
Drug treatments
Dietary molecular supplements
Regenerative and stem-cell-related approaches
Surgeries
Preventions
When to see doctors
What to eat and what to avoid
Frequently asked questions

Charcot-Marie-Tooth disease type 2 caused by mutation in the AARS1 gene is a very rare type of inherited nerve disease. Doctors usually call it Charcot-Marie-Tooth disease axonal type 2N (CMT2N). It mainly damages the long wires of the nerves (axons) that carry signals from the spinal cord to the muscles and from the skin back to the brain. Because of this, people slowly develop weakness and thinning of muscles in the feet, legs, hands, and sometimes arms, along with numbness and loss of feeling. MalaCards+2Monarch Initiative+2

Charcot-Marie-Tooth disease (CMT) is a group of inherited nerve diseases that slowly damage the long peripheral nerves in the legs and arms. Type 2 (CMT2) is the “axonal” form, meaning the main wire of the nerve (the axon) is damaged more than the myelin coating. A rare subtype called CMT2N happens when there is a mutation in the AARS1 gene, which makes the enzyme alanyl-tRNA synthetase, important for normal protein building in nerve cells. Faulty AARS1 leads to gradual weakness and wasting of the small muscles of the feet, legs, hands and loss of sensation. There is no cure yet, so treatment is focused on symptom control, keeping mobility, preventing deformity and protecting quality of life. Physiopedia+3ScienceDirect+3iubmb.onlinelibrary.wiley.com+3

The basic problem comes from a change (mutation) in one copy of the AARS1 gene on chromosome 16. This gene gives instructions to make an enzyme called alanyl-tRNA synthetase, which helps build proteins correctly inside cells. When the gene is mutated, the enzyme does not work normally. Nerve cells, especially long motor and sensory nerves in the legs and arms, are very sensitive to this problem and slowly become sick and damaged. PMC+2PubMed+2

CMT2N is usually autosomal dominant. This means a person only needs one faulty copy of the gene (from one parent) to develop the disease. The illness can start in childhood, teenage years, or adult life. It usually gets worse slowly over many years, and many people remain able to walk, sometimes with braces or support. MalaCards+1

Other names

This condition is known by several other names in medical books and genetic databases. These names are useful when reading reports or research papers: MalaCards+2NCBI+2

Charcot-Marie-Tooth disease, axonal, type 2N
CMT2N
Autosomal dominant Charcot-Marie-Tooth disease type 2N
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2N
Charcot-Marie-Tooth neuropathy axonal type 2N
Charcot-Marie-Tooth neuropathy type 2N
Charcot-Marie-Tooth disease type 2 caused by mutation in AARS
AARS-related Charcot-Marie-Tooth disease type 2
AARS1-related CMT2N

All of these names point to the same basic disease, where an AARS1 gene mutation causes an axonal type of Charcot-Marie-Tooth disease.

Types

Doctors do not have strict official “subtypes” inside CMT2N, but research shows that AARS1 mutations can cause a range of related nerve problems. Clinicians often group them by age of onset, severity, and nerve test results. PMC+2PubMed+2

Typical CMT2N (classic form)
This is the most common pattern. People develop slowly progressive weakness in the feet and lower legs, high-arched feet, and later weakness in the hands. Nerve conduction studies show an axonal pattern with relatively normal or only slightly reduced conduction speed.
Early-onset CMT2N
In some families the disease starts in childhood. Children may walk late, trip often, or have early foot deformities. The same AARS1 mutation can sometimes cause earlier or later onset in different family members, showing variable expressivity. Frontiers+1
Adult-onset CMT2N
In other people, symptoms first appear in young or middle adulthood. They may notice mild foot drop, ankle weakness, or hand weakness only after years of normal activity. Progression is usually slow. MalaCards+1
Intermediate CMT due to AARS1 mutation
Some patients with an AARS1 mutation have nerve conduction speeds that are between demyelinating (CMT1) and axonal (CMT2) values. These cases are sometimes called intermediate CMT, but the genetic cause is still an AARS1 mutation. PubMed+1
Phenotype overlapping distal hereditary motor neuropathy (dHMN)
Research shows that AARS1 mutations can also cause more “motor-only” nerve disease, where muscle weakness is much more obvious than sensory loss. This pattern overlaps with distal hereditary motor neuropathy. American Academy of Neurology+1
Mild CMT2N
Some family members with the same mutation have very mild symptoms, such as slight foot weakness or mild sensory change, and may remain almost fully active with little disability. MalaCards+1
Moderate to severe CMT2N
Others may develop more obvious weakness, need ankle-foot orthoses (AFOs) or walking aids, and sometimes have marked hand weakness and muscle wasting. Even in these cases, progression is usually slow over many years. PMC+1

These “types” mainly describe how the disease looks in real life, not different genetic diseases. In all of them, the underlying cause is a pathogenic mutation in AARS1.

Causes

Pathogenic mutation in the AARS1 gene (main cause)
The true basic cause of CMT2N is a harmful change (pathogenic variant) in one copy of the AARS1 gene. This change alters the structure or function of the alanyl-tRNA synthetase enzyme and leads to axonal neuropathy. PMC+2PubMed+2
Autosomal dominant inheritance from an affected parent
Many patients inherit the mutation directly from a parent who also has CMT2N, sometimes in a milder form. Each child of an affected person has a 50% chance of receiving the mutated gene. NCBI+1
De novo AARS1 mutation (new mutation)
In some people the mutation appears for the first time in them and is not found in either parent. This is called a de novo mutation. The person can then pass it to their own children.
Loss of normal alanyl-tRNA synthetase enzyme activity
Some mutations reduce the enzyme’s ability to attach the amino acid alanine to its tRNA during protein production. This loss-of-function effect can disturb protein building in nerve cells and make them fragile. PMC+2Springer Link+2
Toxic gain-of-function effect of the mutant enzyme
Other AARS1 mutations may not only weaken the enzyme but also give it a new, harmful activity, such as abnormal binding to other proteins or mis-localization in the cell. This is called a toxic gain-of-function and can trigger nerve cell stress. Springer Link+1
Axonal degeneration of long peripheral nerves
Because leg and arm nerves are very long, they are more sensitive to any problem with protein handling. Over time, the long axons slowly degenerate from the ends, causing weakness, muscle wasting, and loss of feeling in the feet and hands. MalaCards+1
Impaired axonal transport
Nerve axons must carry nutrients and cell parts along very long distances. AARS1 mutations may disturb this axonal transport, so the ends of the nerves do not receive enough support, leading to further damage and loss of nerve function. Springer Link+1
Cell stress and misfolded protein response
When protein synthesis is abnormal, misfolded proteins can build up in nerve cells and activate stress pathways such as the unfolded protein response. Long-term cell stress may contribute to chronic axonal injury in CMT2N. Springer Link+1
Mitochondrial stress and energy problems
Nerve cells need a lot of energy. Keeping axons alive and active requires many healthy mitochondria. Disturbed protein synthesis and cell stress in CMT2N may cause mitochondrial dysfunction, reducing energy supply and making axons more likely to degenerate. Springer Link+1
Age-related wear on vulnerable nerves
Even though the mutation is present from birth, nerves may cope for many years. As a person grows older, normal age-related wear and tear adds to the genetic weakness, and symptoms appear or slowly worsen.
Additional variants in other neuropathy-related genes (genetic burden)
Some people with AARS1 mutations also carry other rare variants in different nerve genes. This genetic burden can modify how severe the disease is and what age it starts. PMC+2Springer Link+2
Diabetes mellitus (worsening factor, not the primary cause)
Diabetes itself can damage peripheral nerves. In a person who already has CMT2N due to AARS1, poorly controlled blood sugar may make numbness, pain, and weakness worse and speed up disability.
Chronic alcohol misuse (worsening factor)
Long-term heavy drinking can cause toxic neuropathy. In CMT2N, chronic alcohol use can add extra damage to nerves that are already weak and increase symptoms.
Vitamin B12 deficiency or other nutritional problems
Lack of vitamin B12, folate, or other nutrients can cause neuropathy. If a person with CMT2N develops these deficiencies, they may experience extra numbness and weakness beyond what the genetic disease alone would cause.
Mechanical compression of nerves (pressure neuropathy)
Tight shoes, frequent squatting, or long sitting with crossed legs can compress peripheral nerves. In CMT2N, such pressure injuries can worsen foot drop, weakness, or numbness because the nerves are already vulnerable.
Repetitive ankle or foot trauma
People with weak ankles and high-arched feet often twist their ankles or trip. Repeated sprains and micro-injuries around the ankle and foot may further damage local nerves and tendons and increase disability.
Severe weight loss and muscle wasting
If a person loses a lot of weight or muscle bulk from any cause (illness, eating problems), the muscles already affected by CMT2N may become even weaker and thinner, making walking and hand use harder.
Lack of physical activity and physiotherapy
Muscles and joints need regular movement to stay strong and flexible. Without appropriate exercise and physiotherapy, joint stiffness, contractures, and further weakness can develop on top of the genetic nerve damage.
Unsafe footwear and poor foot care
Shoes without support, or walking barefoot on uneven ground, can raise the risk of falls, ankle injuries, and skin ulcers in numb feet. Poor foot care does not cause CMT2N but can make its consequences much worse.
Delayed diagnosis and lack of supportive care
When the disease is not recognized for many years, people may not receive braces, orthotics, or therapy that could protect their mobility. This delay can lead to avoidable contractures, deformities, and loss of function.

Symptoms

Slowly progressive weakness of the feet and lower legs
The most typical symptom is gradual weakness of the muscles that lift the front of the foot and move the ankle. People may notice that they trip often, cannot run as before, or have difficulty walking on their heels. This reflects axonal loss in peroneal and tibial motor nerves. MalaCards+1
Foot drop and slapping gait
Because the ankle cannot lift well, the front of the foot may hang down during walking. The person must lift the knee higher, and the foot may land with a “slap” on the floor. This is called foot drop and is a very common sign in axonal CMT. MedlinePlus
High-arched feet (pes cavus) and toe deformities
Over time, muscle imbalance in the foot causes the arch to become very high and the toes to curl (hammer toes or claw toes). These deformities can make shoe fitting hard and increase pressure on certain areas of the foot. MalaCards+1
Weakness and thinning of muscles in the calves
The calf muscles often become thin (atrophic), giving the leg a “stork leg” or “inverted champagne bottle” appearance. This is due to long-term loss of motor axons and poor muscle stimulation. MalaCards+1
Numbness and reduced feeling in feet and toes
Many people with CMT2N notice numbness, reduced light touch, and reduced vibration sensation in the feet and toes. This happens because sensory nerve fibers are damaged and cannot carry signals normally. MalaCards+1
Tingling, burning, or electric-like pain
Some patients experience neuropathic pain, described as burning, tingling, pins-and-needles, or electric shocks in the feet or lower legs. This type of pain comes from irritated or malfunctioning sensory nerves.
Weakness in hands and fingers
As the disease progresses, the same process can affect the small muscles of the hands. People may have trouble opening jars, buttoning clothes, writing, or using tools. Muscle wasting may be visible between the thumb and index finger. MalaCards
Reduced or absent ankle reflexes
On examination, doctors often find that ankle jerks (Achilles reflexes) are absent, and knee reflexes are reduced. This reflects damage to the afferent and efferent parts of the reflex arc in the peripheral nerves. MalaCards+1
Balance problems and unsteady walking
Numb feet and weak ankles make it hard for the brain to know where the feet are. This loss of “position sense” and strength can cause poor balance, especially in the dark or on uneven ground, leading to frequent tripping and falls. MalaCards+1
Fatigue and easy tiredness in legs and arms
Everyday tasks may require much more effort because weak muscles must work hard. People may feel tired after short walks, standing in line, or performing manual tasks.
Cramps and muscle spasms
Some patients report cramps or sudden tightness in the calves, feet, or hands, especially at night or after activity. These spasms reflect unstable nerve firing and weak, irritable muscles.
Decreased cold and heat sensation
Injured sensory nerves may not carry temperature information normally. People may have reduced ability to feel hot or cold in their feet, raising the risk of burns or frostbite if not careful.
Foot and ankle pain from deformity and strain
High arches, claw toes, and unstable ankles can cause mechanical pain in joints, ligaments, and tendons. This pain is different from burning nerve pain and is usually worse with standing or walking.
Difficulty running, jumping, or climbing stairs
Because of weakness and poor balance, tasks that need fast, strong movements, such as running or climbing stairs quickly, become hard or impossible. Many people adjust by walking slower and using handrails.
Psychological stress and lowered self-confidence
Living with a chronic, slowly worsening condition can cause worry, sadness, or loss of self-confidence, especially if walking becomes limited or visible deformities develop. Emotional support and counseling can be very helpful.

Diagnostic tests

Physical examination–based tests

Complete neurological examination
The doctor carefully checks muscle strength, muscle size, reflexes, and sensation in the legs, arms, hands, and feet. In CMT2N, they often find distal weakness, muscle wasting, loss of ankle reflexes, and reduced sensation in a “stocking-glove” pattern. This exam gives the first strong clue that a length-dependent peripheral neuropathy is present. MalaCards+2Monarch Initiative+2
Gait and walking observation
The doctor watches how the person walks. Typical findings in CMT2N are foot drop, high-stepping gait, and foot slap. They may also look at running, heel walking, and toe walking. These simple bedside tests show how much the neuropathy affects daily movement.
Inspection of feet, legs, and hands for deformities
The clinician inspects for high-arched feet, hammer toes, claw toes, thin calves, and hand muscle wasting. These visible changes help distinguish long-standing inherited neuropathy from short-term acquired nerve problems. MalaCards+1
Balance tests (Romberg and single-leg stance)
In the Romberg test, the person stands with feet together, arms by the side, first with eyes open and then closed. People with CMT2N may sway or fall when their eyes are closed because they rely heavily on vision to compensate for poor position sense in the feet. Standing on one leg is also often unstable.
Functional mobility tests (e.g., Timed Up and Go)
In a simple clinic test, the person is asked to stand up from a chair, walk a short distance, turn, walk back, and sit down while the time is measured. Slowness, need for support, or unsafe turns show the practical impact of the neuropathy on everyday mobility.

Manual bedside tests

Manual muscle testing (MMT)
The doctor or physiotherapist tests strength by pushing against the patient’s foot or hand in different directions and grading the power on a standard scale (0 to 5). In CMT2N, the weakest muscles are usually ankle dorsiflexors, toe extensors, and small hand muscles.
Deep tendon reflex testing
Using a small rubber hammer, the doctor taps knee and ankle tendons to check reflexes. In CMT2N, knee reflexes are often reduced and ankle reflexes are usually absent, confirming lower motor neuron involvement in the peripheral nerves. MalaCards+1
Vibration sense with a tuning fork
A vibrating tuning fork is placed on the big toe, ankle, or finger joints. People with CMT2N often feel the vibration less strongly or for a shorter time than normal, showing damage to large sensory fibers that carry vibration and position sense.
Light touch and pin-prick sensory testing
The doctor gently touches the skin with a cotton wisp (for light touch) and a blunt pin (for pain). In CMT2N, sensation is usually reduced in the feet and lower legs first, sometimes also in the hands, following a length-dependent pattern.
Joint position sense testing
The examiner moves the toes or fingers up and down with the eyes closed and asks the person to say what direction they feel. Poor performance shows proprioceptive loss, which contributes to imbalance and unsteady gait in CMT2N.

Laboratory and pathological tests

Blood tests to exclude other causes of neuropathy
Doctors often order routine blood tests such as blood sugar (for diabetes), vitamin B12, folate, thyroid function, kidney and liver tests, and sometimes autoimmune or infection markers. These do not diagnose CMT2N directly but help rule out more common acquired neuropathies that might mimic or worsen symptoms. MedlinePlus
Genetic testing for AARS1 and other CMT genes
The key confirmatory test is DNA analysis from a blood sample. A panel for CMT or neuropathy genes is sequenced, including AARS1. Finding a known pathogenic or likely pathogenic AARS1 variant in a person with compatible symptoms confirms the diagnosis of AARS1-related CMT2N. NCBI+2PubMed+2
Segregation testing in family members
After a mutation is found, doctors may test parents, siblings, or children to see who else carries the same AARS1 variant. If the variant is present in affected relatives and absent in healthy relatives, this segregation pattern strengthens the evidence that it truly causes the disease. PubMed+1
Serum protein electrophoresis and immunofixation
In adults, doctors may check for abnormal proteins in the blood (paraproteins) that can cause neuropathy, such as in some blood cancers. A normal result helps rule out these acquired causes, supporting the diagnosis of inherited neuropathy like CMT2N.
Cerebrospinal fluid (CSF) examination (in selected cases)
Lumbar puncture and CSF analysis are not routine for CMT2N, but may be done if the doctor suspects an inflammatory neuropathy. In CMT2N, CSF is usually normal, while some acquired inflammatory neuropathies show raised protein or cells.
Nerve biopsy (rarely needed)
A small piece of a sensory nerve (often in the leg) may be removed for study under the microscope. Today this is rarely required because genetic testing is much better and safer. If done, CMT2N usually shows axonal loss with relatively preserved myelin, fitting its classification as an axonal neuropathy. MalaCards+1

Electrodiagnostic tests

Nerve conduction studies (NCS)
Small electrical pulses are given over the nerves, and the responses are recorded. In CMT2N, nerve conduction studies typically show reduced amplitudes of sensory and motor responses, meaning fewer working axons, while conduction velocities are normal or only mildly slowed, consistent with an axonal neuropathy rather than a demyelinating one. MalaCards+2Springer Link+2
Electromyography (EMG)
A fine needle electrode is placed into muscles to record their electrical activity. EMG in CMT2N shows signs of chronic denervation and re-innervation, such as large motor unit potentials, which reflect long-standing axonal loss and collateral sprouting by surviving motor units. These findings help distinguish CMT2N from muscle disease and from some acquired neuropathies.

Imaging tests

MRI of legs or peripheral nerve MR neurography (selected cases)
Magnetic resonance imaging (MRI) of the lower legs can show patterns of muscle wasting and fatty replacement typical of chronic neuropathy. Special MR neurography techniques can sometimes show thickened or abnormal peripheral nerves. Imaging is mainly used to rule out other structural causes (such as nerve root compression or plexus lesions) and to document the pattern of muscle involvement.
Foot and ankle X-rays or MRI
X-rays or MRI of the feet and ankles may be used to assess bone alignment, joint damage, and severity of deformities such as pes cavus and claw toes. This information helps orthopedic surgeons and podiatrists plan braces, orthotics, or corrective surgery if needed, even though it does not directly measure nerve damage.

Non-pharmacological treatments (therapies and others)

Below are common non-drug treatments used in CMT2 (including AARS-related CMT2N). Together they aim to keep you walking, reduce pain and delay disability. Pod NMD+5PMC+5Charcot-Marie-Tooth Association+5

1. Physical therapy and stretching
A regular program with a trained physiotherapist is one of the most important treatments. Gentle stretching keeps muscles and tendons flexible, which reduces stiffness and contractures in the ankles and toes. Strength work for less-affected muscles helps them support weak muscles and improves walking and standing. Therapy is usually low-impact, repeated many times per week, and adjusted so it does not cause extra fatigue or pain.

2. Strength training of remaining muscles
Because some muscles become weak earlier than others, therapists focus on strengthening the muscles that are still working reasonably well. Simple exercises with body weight, light bands or small weights can preserve power in hips, thighs, shoulders and trunk. Stronger “proximal” muscles help compensate for weak feet and hands, making everyday actions like climbing stairs, standing from a chair and lifting objects safer and easier.

3. Balance and gait training
Nerve damage affects feeling in the feet and ankle control, so people with CMT2 often trip or feel unsteady. Specific balance exercises on flat and slightly unstable surfaces, combined with careful practice of stepping, turning and walking, help the brain relearn how to control posture. Therapists may use markers on the floor or railings to guide safe practice and to reduce the risk of falls in daily life.

4. Occupational therapy for hand and daily-task skills
Occupational therapists focus on hand weakness, clumsiness and fatigue during daily tasks. They teach joint-protecting ways to hold objects, use larger grips and adapt writing, buttoning, cooking and computer work. They can recommend tools such as built-up pens, button hooks and easy-grip cutlery. This support helps you stay independent at home, at school and at work even if fine finger movements are slower.

5. Ankle-foot orthoses (AFOs)
Light braces worn inside or over the shoe hold the ankle in a safer position and prevent the toes from dragging. They are custom-made plastic or carbon-fiber shells that support weak muscles but still allow some movement. AFOs improve foot clearance, reduce tripping and help correct “foot drop.” They can also lessen fatigue by making every step more efficient and stable during long walks.

6. Custom shoes and insoles
Special shoes with extra depth, firm heel counters and rocker soles can reduce pressure on the front of the foot and improve push-off. Soft, custom insoles spread weight more evenly to protect numb areas from skin breakdown. Good footwear works together with AFOs to keep the foot in a plantigrade (flat) position, ease pain from deformities and help keep you active longer.

7. Night splints for the feet and ankles
Wearing gentle splints at night can hold the ankle in a neutral or slightly stretched position while you sleep. This reduces the tendency of the Achilles tendon to shorten and the toes to curl. Over time, this can slow down fixed deformities and make walking less painful. Splints are usually lightweight and designed to allow comfortable sleep while maintaining a mild stretch.

8. Hand splints and wrist supports
Soft or rigid splints can support weak wrist and finger muscles, especially when using tools or keyboards for long periods. They hold joints in functional positions, limit over-stretching of weak ligaments and help reduce pain from overuse. Wearing splints during specific tasks (not all day) can improve grip and reduce cramping, making school and office work more manageable.

9. Regular aerobic exercise
Low-impact aerobic activities like walking on level ground, swimming, cycling or using an arm-crank machine can improve heart health, stamina and mood. Research in CMT suggests that supervised endurance training improves work capacity and reduces fatigue without worsening nerve damage if done safely. The typical aim is around 150 minutes per week of moderate activity, split into short sessions. PMC+2Charcot-Marie-Tooth Disease+2

10. Weight management and nutrition counseling
Extra body weight makes every step harder for weak muscles and increases the risk of joint pain and falls. Working with a dietitian helps you find a realistic eating plan to keep a healthy weight. Balanced meals with enough protein, vitamins and minerals support muscle and nerve health and provide energy for therapy and daily life.

11. Fall-prevention and home modifications
Simple changes at home reduce injuries: removing loose rugs, adding grab bars and railings, improving lighting and using non-slip mats in the bathroom. An occupational therapist may do a home safety assessment and suggest rearranging furniture to create clear walking paths. These changes help you move more confidently and lower the risk of fractures and head injuries from falls.

12. Pain psychology and cognitive-behavioral therapy (CBT)
Chronic nerve pain and fatigue can lead to worry, low mood and poor sleep. Working with a psychologist used to chronic illness can teach coping tools, relaxation breathing and strategies to manage stress. CBT helps people change unhelpful thoughts about pain, which can reduce the overall pain experience and improve participation in physiotherapy and daily activities. Charcot-Marie-Tooth Association+1

13. Energy conservation and fatigue management
Many people with CMT2 feel tired easily. Therapists teach you to plan the day, alternate heavy and light tasks, sit instead of stand when possible and use devices like trolleys to move objects. Learning to rest before you are exhausted prevents “boom-and-bust” cycles and keeps you able to attend school, work and social activities more regularly.

14. Walking aids (cane, crutches, walker)
If balance is poor or falls are frequent, a simple assistive device can greatly improve safety. A cane or trekking pole may be enough for mild problems; a walker or rollator can help more severe cases. The right device, adjusted to the correct height, reduces strain on weak muscles and can prevent serious injuries from falls.

15. Vocational rehabilitation and school/workplace adaptations
Specialists can help adapt school or work tasks to your abilities. They may suggest ergonomic desks, voice-to-text software, flexible schedules or adjusted physical demands. This support protects your health while allowing you to continue studies or employment, which is vital for mental health and independence.

16. Patient education and genetic counseling
Education about CMT2 and the AARS1 mutation helps you understand what is happening and what to expect. Genetic counseling explains inheritance patterns, family planning options and the meaning of genetic test reports. This information helps families make informed decisions and reduces fear and confusion about the future. ScienceDirect+1

17. Foot care and podiatry
Because sensation is reduced, small skin injuries can go unnoticed and turn into ulcers. Regular visits to a podiatrist for nail care, callus removal and shoe checks are important. Learning to inspect your own feet daily, especially between toes and under the foot, can prevent serious infections and ulcer-related complications.

18. Respiratory and spine monitoring
In most CMT2N patients, breathing muscles are not severely affected, but severe scoliosis or chest deformities can sometimes reduce lung function. Regular check-ups with spine and lung assessments in those with scoliosis or trunk weakness allow early treatment if breathing or posture problems appear. In rare severe cases, non-invasive ventilation at night may be needed.

19. Sleep hygiene and restless-legs management
Nerve discomfort, cramps and worry can disturb sleep. A regular sleep schedule, a quiet dark room, limiting caffeine in the evening and stretching before bed can help. If restless legs or strong night pain appear, doctors may adjust medications or recommend other strategies, because good sleep is vital for nerve repair and daytime energy.

20. Peer support groups and mental-health care
Living with a life-long nerve disease is emotionally hard. Support groups (in person or online) allow you to share experiences and tips with others who understand CMT. Counseling or therapy can help manage anxiety, sadness or frustration. Good mental health makes it easier to follow therapy plans and maintain relationships and hobbies.

Drug treatments

There is no medicine currently approved specifically to cure CMT2 due to AARS1 mutation. Drug treatment focuses on symptoms such as neuropathic pain, muscle cramps, mood problems and sleep. Many medicines below are approved by the U.S. FDA for other neuropathic pain conditions (like diabetic nerve pain or postherpetic neuralgia) on accessdata.fda.gov and are sometimes used for CMT-related pain by analogy. Exact choice and dose must be decided by a neurologist for each person. FDA Access Data+16Charcot-Marie-Tooth Association+16ScienceDirect+16

To keep within your word limit, I will explain the key medicines in more detail and list the others more briefly.

1. Gabapentin (Neurontin, Gralise – antiepileptic, gabapentinoid)
Gabapentin is approved for postherpetic neuralgia and seizures and is widely used for neuropathic pain. Adult neuropathic-pain doses often range from 900 to 3600 mg per day split into three doses, but doctors start low and increase slowly. It works by binding to calcium channels in nerve cells and reducing abnormal pain signals. Common side effects include dizziness, sleepiness, swelling of legs and weight gain. People must not stop suddenly without medical advice because of seizure risk in some patients. FDA Access Data+3FDA Access Data+3FDA Access Data+3

2. Pregabalin (Lyrica, Lyrica CR – antiepileptic, gabapentinoid)
Pregabalin is FDA-approved for several neuropathic pain conditions and fibromyalgia. Typical adult doses for neuropathic pain are 150–600 mg per day in two or three doses, starting at 75 mg twice daily and titrating as needed and tolerated. It dampens overactive nerve firing by binding to the same calcium-channel subunit as gabapentin. Side effects include dizziness, drowsiness, blurred vision, weight gain and ankle swelling. Doctors monitor for mood changes and adjust the dose in kidney disease. FDA Access Data+4FDA Access Data+4FDA Access Data+4

3. Duloxetine (Cymbalta – serotonin-norepinephrine reuptake inhibitor, SNRI)
Duloxetine is approved for diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain. Typical adult doses for neuropathic pain are 60 mg once daily, sometimes starting at 30 mg for one week for tolerability. It increases serotonin and noradrenaline in pain-modulating pathways in the brain and spinal cord, which can reduce nerve pain. Frequent side effects include nausea, dry mouth, sleepiness or insomnia, constipation and sweating. It is usually avoided in serious liver disease and used with caution in people at risk of suicidal thoughts. FDA Access Data+4FDA Access Data+4FDA Access Data+4

4. Venlafaxine (SNRI antidepressant)
Venlafaxine is approved for mood disorders but is sometimes used off-label for neuropathic pain when duloxetine is not suitable. It increases serotonin and noradrenaline, which can dampen pain signals. Dosing is usually once or twice daily in extended-release form, with dosage guided by mental-health and pain status. Side effects can include nausea, raised blood pressure, sleep disturbance and sexual dysfunction, so close medical follow-up is needed.

5. Amitriptyline (tricyclic antidepressant, TCA)
Amitriptyline is an older antidepressant commonly used at low doses at night to treat nerve pain and improve sleep. It blocks reuptake of serotonin and noradrenaline and also affects sodium channels, which reduces nerve firing. Typical neuropathic-pain doses are much lower than depression doses (for example 10–50 mg at bedtime in adults), adjusted individually. Side effects include dry mouth, constipation, blurred vision, weight gain and next-day drowsiness; it is used cautiously in heart disease.

6. Nortriptyline (TCA)
Nortriptyline is related to amitriptyline but sometimes better tolerated. It has similar mechanisms and is used in similar low night-time doses for nerve pain. Side effects can include dry mouth, constipation and heart rhythm changes, so doctors usually start very low and monitor, especially in older adults or those with heart problems.

7. Oxcarbazepine (antiepileptic, sodium-channel blocker)
Oxcarbazepine is primarily an anti-seizure medicine but can help some people with neuropathic pain by stabilizing overactive sodium channels in nerve membranes. Doses are slowly increased to avoid side effects such as dizziness, sleepiness and low sodium in the blood. It may be considered when first-line neuropathic-pain drugs fail but must be monitored by a neurologist.

8. Lamotrigine (antiepileptic)
Lamotrigine also targets sodium channels and may help in certain neuropathic pain conditions. The dose must be increased very slowly to reduce the risk of serious skin reactions such as Stevens–Johnson syndrome. Because of this risk, lamotrigine is usually reserved for cases where other drugs are not effective or tolerated, and it requires careful medical supervision.

9. Topical lidocaine 5% patch
Lidocaine patches are applied over painful skin areas (for example, the top of the foot) for up to 12 hours per day. Lidocaine blocks sodium channels in small nerve endings, numbing the area and reducing burning or shooting pain. Systemic side effects are low because little drug enters the bloodstream, but skin irritation or redness can occur. These patches are FDA-approved for postherpetic neuralgia and often used for other localized neuropathic pain.

10. Topical capsaicin (cream or high-strength patch)
Capsaicin is the active compound from chili peppers. In high concentration it temporarily “overloads” pain nerve endings and then reduces their sensitivity for many weeks. Creams are applied several times per day; a special high-strength patch is placed in a clinic. Early burning or stinging is common but usually fades. It is mainly used for localized nerve pain rather than widespread symptoms.

11. Non-steroidal anti-inflammatory drugs (NSAIDs such as ibuprofen, naproxen)
NSAIDs are not very effective for true neuropathic pain but can help with joint and muscle pain caused by abnormal walking, foot deformities or overuse. Doses depend on the specific drug and age. Side effects can include stomach irritation, kidney problems and increased bleeding risk, especially with long-term use, so they should be used at the lowest effective dose and under medical guidance.

12. Acetaminophen (paracetamol)
Acetaminophen can reduce mild musculoskeletal pain and is often used as a first step before stronger pain medicines. It does not treat nerve pain itself but may make overall pain more manageable. Doses must stay within safe daily limits to avoid liver damage. It is often combined with other treatments, including physiotherapy and neuropathic-pain drugs.

13. Tramadol (weak opioid and SNRI-like drug)
Tramadol acts on opioid receptors and also affects serotonin and noradrenaline. It may help moderate neuropathic pain when first-line medicines fail. Because it can cause dependence, dizziness, nausea and risk of serotonin syndrome or seizures, it is usually a second-line option and should be used for limited periods, under strict prescription and monitoring.

14. Baclofen (muscle relaxant)
Baclofen is a muscle relaxant that acts on GABA receptors in the spinal cord to reduce muscle tone and spasms. In CMT2 it can help some people with painful cramps or stiffness. Doses start low and increase slowly to minimize sleepiness, weakness and dizziness. Stopping baclofen suddenly can cause rebound spasticity, so doses are reduced gradually.

15. Tizanidine (muscle relaxant)
Tizanidine works on alpha-2 receptors to reduce muscle spasm. It may help people whose walking is made harder by tight, cramping muscles. Side effects include sleepiness, dry mouth and low blood pressure, so blood pressure and liver tests are sometimes monitored.

16. Low-dose benzodiazepines (for severe night cramps – very cautious use)
In rare difficult cases, short-term low doses of benzodiazepines like clonazepam may be used at night for severe cramps or restless legs. They act on GABA receptors to calm the nervous system but have risks of dependence, daytime drowsiness and falls, so many doctors avoid them or use them only briefly and with great care, especially in young people.

17. SSRIs or SNRIs for anxiety and depression
Living with chronic pain and disability can cause mood problems. Selective serotonin reuptake inhibitors (SSRIs) or SNRIs (like duloxetine or venlafaxine) can treat anxiety and depression and may also help with pain perception. Doses and choice depend on psychiatric assessment. Side effects vary by drug and include nausea, sleep changes and sexual side effects.

18. Sleep medicines (short-term use)
If pain keeps you awake, doctors sometimes use short-term sleep aids (for example low-dose trazodone or melatonin). The aim is to break the cycle of insomnia and pain. These medicines are used with non-drug sleep strategies and monitored closely to avoid dependence or next-day drowsiness.

19. Vitamin B12 injections when deficient
If blood tests show low vitamin B12, injections can help repair and protect nerves. B12 is essential for myelin and axon health. In people with both CMT2 and B12 deficiency, correcting the deficiency may improve feeling or stop additional damage, even though it does not cure the genetic disease. Side effects are usually mild.

20. Other adjuvant medicines based on individual needs
Depending on the person, doctors may use other drugs such as low-dose anti-spasticity agents, antidepressants, or migraine treatments. These are chosen case-by-case, often following general neuropathic-pain guidelines rather than CMT-specific trials, because CMT2N is very rare and formal drug studies are limited.

Dietary molecular supplements

Evidence for supplements in CMT2N is limited. Some nutrients support general nerve health and may be suggested as part of a balanced plan, especially if deficiency is present. Always discuss doses with your doctor.

Vitamin B12 (methylcobalamin) – Important for myelin and axon health. Oral doses often 500–1000 micrograms daily if low intake; injections for proven deficiency. Helps prevent additional neuropathy from B12 lack.
Folate (vitamin B9) – Supports DNA synthesis and repair. Typical oral doses 400–800 micrograms daily in adults. Deficiency can worsen anemia and nerve symptoms.
Vitamin B1 (thiamine) or benfotiamine – Needed for energy production in nerves. Doses vary (for example 50–100 mg/day in adults under supervision). May help in diabetic neuropathy; in CMT can prevent added damage from deficiency.
Alpha-lipoic acid – An antioxidant used in some studies of diabetic neuropathy. Oral doses like 300–600 mg/day have been studied in adults; may reduce burning pain and oxidative stress but evidence is mixed.
Omega-3 fatty acids (fish-oil EPA/DHA) – Anti-inflammatory fats that support cell membranes. Common doses 500–1000 mg/day combined EPA/DHA. May support general cardiovascular and nerve health.
Coenzyme Q10 – Involved in mitochondrial energy production. Doses in studies often 100–300 mg/day. May be helpful where mitochondrial stress is suspected, though evidence in CMT is limited.
Acetyl-L-carnitine – Helps energy transport in mitochondria and has been studied in some neuropathies. Doses like 500–1000 mg once or twice daily are common in research; may reduce pain and improve nerve regeneration in some conditions.
Vitamin D – Important for bone, muscle and immune health. Dose is based on blood level (for example 600–2000 IU/day in adults, adjusted by doctor). Adequate vitamin D helps prevent fractures in people at fall risk.
Magnesium – Involved in muscle relaxation and nerve function. Supplementation may help cramps in some people; typical doses 200–400 mg/day of elemental magnesium under medical guidance, to avoid diarrhea or kidney issues.
Curcumin or resveratrol (plant polyphenols) – Antioxidant and anti-inflammatory compounds studied in experimental nerve models. Human dosing varies by product; they are considered add-ons to a healthy diet, not stand-alone treatments.

Regenerative and stem-cell-related approaches

For AARS-related CMT2N, no regenerative or stem-cell drug is approved yet. Research areas (mostly in labs and early trials) include:

Gene-replacement therapy for AARS1 – Future strategies may try to deliver a healthy copy of the AARS1 gene to nerve cells using viral vectors. The goal is to correct the underlying protein problem. Doses and schedules are still experimental in animal models; none are approved for human CMT2N yet. ScienceDirect+2iubmb.onlinelibrary.wiley.com+2
Gene-editing approaches (CRISPR-based) – Scientists are exploring tools that might one day repair or silence harmful mutations directly in DNA. For now, these remain research concepts, and safety, delivery and off-target effects are still under study.
Neurotrophic-factor therapies (e.g., neurotrophin-3) – Some studies in CMT have tested growth factors that support nerve survival and regrowth. These treatments aim to nourish damaged axons and improve conduction, but they are still investigative and not routine treatment.
Mesenchymal stem-cell infusions – Experimental work is looking at stem cells from bone marrow or fat that release helpful growth factors and anti-inflammatory molecules. These may support nerve repair indirectly. At present they should only be used in properly regulated clinical trials, not in unproven private clinics.
Small-molecule modifiers of tRNA-synthetase function – Because AARS1 is a tRNA synthetase, researchers are interested in small molecules that might correct misfolding or abnormal signaling of these enzymes. These drugs are in pre-clinical stages and have no standard doses yet.
Mitochondrial-protective agents – Some potential drugs target mitochondrial stress and oxidative damage in nerve cells. They are being studied broadly in peripheral neuropathy models but are not yet approved as disease-modifying CMT treatments.

Surgeries

1. Foot deformity correction (osteotomy)
Long-term muscle imbalance can cause high-arched (cavus) feet, claw toes and instability. Surgeons may cut and realign foot bones (osteotomies) to create a flatter, more stable foot. This can reduce pain, improve shoe fit and make walking safer. Surgery is usually considered when braces and physiotherapy no longer give enough support. Mayo Clinic+2Physiopedia+2

2. Tendon transfer surgery
In tendon transfer, a working tendon is moved to take over the job of a weak muscle, for example moving a functioning tendon to lift the front of the foot and correct foot drop. This balances forces around the ankle, improves the way the foot lands during walking and can delay or reduce the need for ankle fusion later.

3. Joint fusion (arthrodesis)
If joints are very unstable or painful, surgeons may fuse them so bones grow together, especially in the midfoot or ankle. This removes movement in that joint but can create a more stable platform for walking. It is usually reserved for severe deformity or arthritis when other surgeries are not enough.

4. Toe-straightening procedures
Claw toes can rub in shoes, causing painful corns and ulcers. Minor surgeries to lengthen tendons, remove small pieces of bone or fuse toe joints can straighten the toes. This reduces pain, makes it easier to wear normal shoes and helps prevent sores in people with reduced sensation.

5. Nerve-decompression surgeries (e.g., carpal or tarsal tunnel release)
Because nerves are already fragile in CMT, additional compression (for example in the wrist or ankle tunnels) can cause extra symptoms. Decompression surgery cuts the tight band pressing on the nerve. This may relieve numbness, tingling and pain and protect remaining nerve function in that area.

Preventions

You cannot prevent being born with an AARS1 mutation, but you can prevent many complications and slow down disability:

Avoid nerve-toxic medicines (for example some chemotherapy drugs, certain antibiotics) whenever possible; always tell doctors you have hereditary neuropathy.
Keep a healthy body weight to reduce stress on weak muscles and joints and make walking easier.
Do regular, safe exercise to maintain strength, flexibility and heart health without over-fatigue.
Protect your feet with proper shoes, daily inspections and podiatry visits to avoid ulcers and infections.
Prevent falls by using braces or walking aids as advised and making home modifications.
Control other medical conditions such as diabetes, thyroid disease or vitamin deficiencies that can worsen neuropathy.
Avoid smoking and heavy alcohol use, which can damage nerves and blood vessels.
Maintain good bone health with enough calcium, vitamin D, exercise and fall prevention to reduce fracture risk.
Attend regular neurologist and rehabilitation visits to adjust braces, exercises and medicines early.
Use genetic counseling for family planning to understand inheritance risk and options.

When to see doctors

You should see a doctor (ideally a neurologist experienced in neuromuscular disease) for regular follow-ups even if you feel stable. Urgent or earlier review is important if you notice:

New or rapidly worsening weakness, especially if you suddenly cannot lift your foot or hand.
More frequent falls, severe balance problems or new trouble climbing stairs.
New, strong, burning or electric-shock-like pain that does not settle.
Foot sores, blisters or color changes that do not heal quickly.
New breathing difficulty, loud snoring with daytime sleepiness, or trouble swallowing.
Increasing back curve (scoliosis), hip or knee pain that affects walking.
Persistent low mood, anxiety or thoughts of harming yourself – you deserve mental-health support as part of your care.

What to eat and what to avoid

Eat plenty of colorful vegetables and fruits – they give vitamins, minerals and antioxidants that support general nerve and muscle health.
Choose whole grains like brown rice, oats and whole-wheat bread to provide steady energy for muscles and therapy sessions.
Include lean protein such as fish, eggs, beans and lean meat to help maintain muscle mass.
Use healthy fats like olive oil, nuts, seeds and oily fish for omega-3s that support cell membranes.
Ensure enough calcium and vitamin D from dairy or fortified foods (or supplements if needed) to keep bones strong and resist fractures from falls.
Limit sugary drinks, sweets and refined carbs that cause weight gain and blood-sugar spikes, which can worsen nerve damage in people with diabetes.
Avoid excess saturated and trans fats from fried and heavily processed foods, which harm heart and vessel health.
Limit salt to reduce swelling and blood-pressure problems, especially if using drugs that cause edema.
Avoid heavy alcohol and smoking because both can directly damage nerves and reduce blood flow to muscles.
Be cautious with very high-dose supplements or fad diets; always check with your doctor or dietitian before starting strong supplements or restrictive diets.

Frequently asked questions

1. Is CMT2 due to AARS1 mutation curable?
At present there is no cure that corrects the AARS1 mutation or fully reverses nerve damage. Treatment focuses on supportive therapies, bracing, pain control and prevention of complications. Research into gene and regenerative therapies is active, and new options may appear in the future, but they are not yet standard care. Physiopedia+2PMC+2

2. Does every person with CMT2N become wheelchair-dependent?
No. Severity is variable even within the same family. Some people have mild weakness and stay mobile with braces and therapy for many years, while others develop more serious disability. Early, consistent rehabilitation and good foot care can delay or reduce the need for wheelchairs.

3. Can exercise make the disease worse?
Gentle, well-supervised exercise generally helps rather than harms. Over-strenuous, high-impact activities that cause repeated injuries or extreme fatigue are discouraged. A physiotherapist can design a safe program that keeps you active without overloading fragile nerves and muscles. Pod NMD+3PMC+3Charcot-Marie-Tooth Association+3

4. Which pain medicine is “best” for CMT2?
Studies show that several classes of neuropathic pain medicines (gabapentinoids, SNRIs, TCAs, sodium-channel blockers) can all provide similar levels of relief. The “best” drug is the one that gives you good pain control with the fewest side effects, chosen by your doctor based on your age, other illnesses and other medicines. Charcot-Marie-Tooth Association+1

5. Are gabapentin and pregabalin safe for long-term use?
They are widely used long term for chronic neuropathic pain, but they can cause side effects such as dizziness, sleepiness, weight gain and swelling. They must be started and adjusted by a doctor, and doses may need to be reduced in kidney problems. Stopping suddenly can cause withdrawal symptoms or seizures in some people, so doses must be tapered. FDA Access Data+8FDA Access Data+8FDA Access Data+8

6. Will supplements alone stop the disease?
No. Supplements may help correct deficiencies and support general nerve health, but they cannot fix the gene mutation or fully stop progression. They should be seen as supportive tools alongside physiotherapy, bracing, healthy lifestyle and, when needed, medicines.

7. Is surgery always needed for foot problems?
No. Many people do well for years with AFOs, good shoes and therapy. Surgery is considered when deformities become rigid, painful or severely limiting, or when frequent ulcers appear. The decision is made after careful assessment by orthopedic and neuromuscular specialists. Mayo Clinic+2Physiopedia+2

8. Can I have children, and what is the risk they will have CMT2N?
Most AARS1-related CMT2N is inherited in an autosomal-dominant pattern, meaning each child of an affected parent has about a 50% chance of inheriting the mutation. Genetic counseling can give more precise information for your family, discuss testing options and talk about reproductive choices. ScienceDirect+1

9. Does CMT affect life expectancy?
In most people with CMT2, including CMT2N, life expectancy is near normal. The main problems are disability, falls, pain and reduced participation in daily activities. Exceptions may occur in very severe or early-onset forms, especially if breathing or swallowing muscles are affected, which is less common in classic CMT2N.

10. Are stem-cell clinics advertised online safe?
Many commercial stem-cell clinics offer expensive treatments without strong scientific evidence or proper regulation. These can be risky and may delay real care. At present, stem-cell or gene-based therapies for CMT2N should only be received as part of ethically approved clinical trials at reputable centers.

11. Can diet alone control my symptoms?
A healthy diet supports overall strength, weight control and energy, which can make symptoms easier to manage and therapy more effective. However, diet alone cannot correct nerve damage from the genetic defect. It is one important part of a full care plan, not a replacement for medical and rehabilitation care.

12. Is CMT2N the same as other CMT2 types?
CMT2N shares many clinical features with other CMT2 forms: distal weakness, foot deformities and sensory loss. The difference is the underlying gene (AARS1) and some details of how the nerve cells are damaged. Diagnosis requires genetic testing; treatment principles are similar across CMT2 types. Charcot-Marie-Tooth Association+2Physiopedia+2

13. What tests are used to diagnose CMT2N?
Doctors use a clinical exam, nerve conduction studies, electromyography, and sometimes nerve ultrasound or MRI. Genetic testing, often with next-generation sequencing panels, is used to identify the AARS1 mutation and rule out other genes. Family history also helps confirm the diagnosis. ScienceDirect+1

14. How often should I see my neurologist and therapists?
Many people with stable disease see their neurologist once a year and physiotherapist or occupational therapist every few months for review and exercise updates. In phases of change, such as growth spurts in teenagers or before and after surgery, visits may be more frequent. Your team will tailor the schedule to your needs.

15. What is the most important thing I can do right now?
The most powerful steps are usually to: stay engaged with regular physiotherapy, protect your feet, keep a healthy weight, manage pain with safe strategies and maintain good mental health. Working closely with a neuromuscular team and asking questions whenever you are unsure helps you stay in control of your care and your future.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.

PDF Documents For This Disease Condition

References

SaveSavedRemoved 0